Monopar Therapeutics has evolved from early radiopharma assets into a more concrete bet with ALXN1840 for rare diseases. Click for this MNPR stock update.

Neste explores how renewable diesel and SAF remain vital for reducing GHG emissions despite recent industry setbacks due to economic and supply chain challenges.

Explore how Adient (NYSE:ADNT) is advancing its transformation strategy through manufacturing strength, operational improvements, and evolving automotive industry trends.